학술논문

PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
Document Type
Article
Source
In: Clinical Lymphoma, Myeloma and Leukemia. (Clinical Lymphoma, Myeloma and Leukemia, 2024)
Subject
Language
English
ISSN
21522669
21522650